Service d'Oncologie Thoracique- Hôpital Sainte Marguerite
Marseille, 13274, France
NCT Number: NCT00767962
Treatment of recurrent primary spontaneous pneumothorax remains controversial and many therapeutic options exist. The aim of this study is to compare pleural symphysis by talc poudrage during medical thoracoscopy and surgical management combining pleural abrasion and blebs or bullae resection for treatment of recurrent primary spontaneous pneumothorax.
Looking for future studies?
Notify Me15 year–55 year
All sexes
Interventional
Not applicable
Marseille, 13274, France
Treatment of recurrent primary spontaneous pneumothorax remains controversial and many therapeutic options exist. What is the best technical option : treatment of the lung and the parietal pleura or treatment of the pleura with pleural symphysis ? Talc pleurodesis performed during medical thoracoscopy and resection of blebs or bullae associated with pleural abrasion during surgical thoracoscopy (or video-assisted thoracic surgery) are the most usual methods. These two procedures have never been compared in a prospective trial. The aim of this study is to compare pleural symphysis by talc poudrage during medical thoracoscopy and surgical management combining pleural abrasion and blebs or bullae resection for treatment of recurrent primary spontaneous pneumothorax.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
talc pleurodesis under medical thoracoscopy for recurrent primary spontaneous pneumothorax
pleurodesis under video-assisted thoracoscopy surgery for recurrent primary spontaneous pneumothorax
Time frame: 36 months
Assistance Publique Hopitaux De Marseille
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05963945
Atelectasis, Cardiomegaly
Havířov, Czechia
View Trial DetailsNCT03098524
Atelectasis, Bleeding
Neuilly-sur-Seine, Île-de-France Region, France
View Trial DetailsNCT06075836
Atelectasis, Bronchial Diseases
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT04630301
Pleural Diseases, Pneumothorax
Baltimore, Maryland, United States
View Trial Details